Accrued Liabilities (Details) (USD $)
In Thousands, unless otherwise specified |
Dec. 31, 2014
|
Dec. 31, 2013
|
---|---|---|
Accrued Liabilities | ||
Accrued sales deductions | $ 8,461supn_AccruedSalesDeduction | $ 1,132supn_AccruedSalesDeduction |
Accrued compensation | 5,784us-gaap_EmployeeRelatedLiabilitiesCurrent | 5,016us-gaap_EmployeeRelatedLiabilitiesCurrent |
Accrued product costs | 3,014supn_AccruedProductCostsCurrent | 3,274supn_AccruedProductCostsCurrent |
Accrued clinical trial and clinical supply costs | 2,942supn_AccruedClinicalTrialAndClinicalSupplyCostsCurrent | 2,253supn_AccruedClinicalTrialAndClinicalSupplyCostsCurrent |
Accrued sales and marketing expenses | 1,017us-gaap_AccruedMarketingCostsCurrent | 1,077us-gaap_AccruedMarketingCostsCurrent |
Accrued interest expense | 639us-gaap_InterestPayableCurrent | 619us-gaap_InterestPayableCurrent |
Other accrued liabilities | 3,630us-gaap_OtherAccruedLiabilitiesCurrent | 1,801us-gaap_OtherAccruedLiabilitiesCurrent |
Total | $ 25,487us-gaap_AccruedLiabilitiesCurrent | $ 15,172us-gaap_AccruedLiabilitiesCurrent |
X | ||||||||||
- Definition
Represents the amount of clinical trial and clinical supply costs accrued. No definition available.
|
X | ||||||||||
- Definition
Represents the amount of product costs accrued. No definition available.
|
X | ||||||||||
- Definition
Represent the amount of accrued sales deduction. No definition available.
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No definition available.
|
X | ||||||||||
- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|